Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study
GW Albers, VE Bates, WM Clark, R Bell, P Verro… - Jama, 2000 - jamanetwork.com
ContextTissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke
approved by the Food and Drug Administration.ObjectiveTo assess the safety profile and to …
approved by the Food and Drug Administration.ObjectiveTo assess the safety profile and to …
Predictors of fatal brain edema in massive hemispheric ischemic stroke
…, J Berrouschot, E Schmutzhard, L Harms, P Verro… - Stroke, 2001 - Am Heart Assoc
Background and Purpose— Early identification of stroke patients at risk for fatal brain edema
may be useful in selecting patients for aggressive interventions. Prior studies suggested …
may be useful in selecting patients for aggressive interventions. Prior studies suggested …
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study
…, EC Jauch, DJ Chang, P Verro… - Journal of Cerebral …, 2006 - journals.sagepub.com
Ischemic brain and peripheral white blood cells release cytokines, chemokines and other
molecules that activate the peripheral white blood cells after stroke. To assess gene …
molecules that activate the peripheral white blood cells after stroke. To assess gene …
Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis
P Verro, PB Gorelick, D Nguyen - Stroke, 2008 - Am Heart Assoc
Background and Purpose— This meta-analysis systematically reviewed randomized controlled
trials comparing aspirin plus dipyridamole with aspirin alone in patients with stroke and …
trials comparing aspirin plus dipyridamole with aspirin alone in patients with stroke and …
Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial
Background and Purpose— Hemicraniectomy and Durotomy Upon Deterioration From
Infarction-Related Swelling Trial (HeADDFIRST) was a randomized pilot study to obtain …
Infarction-Related Swelling Trial (HeADDFIRST) was a randomized pilot study to obtain …
Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience
…, MJ Gorman, VE Bates, SE Kasner, P Scott, P Verro… - Stroke, 2000 - Am Heart Assoc
Background and Purpose—Intravenous tissue plasminogen activator (tPA) administered within
3 hours of symptom onset is the first available effective therapy for acute ischemic stroke (…
3 hours of symptom onset is the first available effective therapy for acute ischemic stroke (…
Signatures of cardioembolic and large‐vessel ischemic stroke
…, Y Tian, D Liu, RJ Turner, M Mesias, P Verro… - Annals of …, 2010 - Wiley Online Library
Objective: The cause of stroke remains unknown or cryptogenic in many patients. We
sought to determine whether gene expression signatures in blood can distinguish between …
sought to determine whether gene expression signatures in blood can distinguish between …
Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location
Background and Purpose— The cause of ischemic stroke remains unclear, or cryptogenic,
in as many as 35% of patients with stroke. Not knowing the cause of stroke restricts optimal …
in as many as 35% of patients with stroke. Not knowing the cause of stroke restricts optimal …
CT angiography in acute ischemic stroke: preliminary results
P Verro, LN Tanenbaum, NM Borden, S Sen, N Eshkar - Stroke, 2002 - Am Heart Assoc
Background and Purpose— We sought to evaluate the ability of CT angiography (CTA) to
determine vessel occlusion before acute stroke treatment and to predict its impact on patient …
determine vessel occlusion before acute stroke treatment and to predict its impact on patient …
Cerebrovascular ischemic events with high positive anticardiolipin antibodies
P Verro, SR Levine, GE Tietjen - Stroke, 1998 - Am Heart Assoc
Background and Purpose—The aim of our study was to characterize the patient profile and
prognostic value associated with high positive IgG (>100 GPL) anticardiolipin antibodies (aCL…
prognostic value associated with high positive IgG (>100 GPL) anticardiolipin antibodies (aCL…